Although many risk factors are well known (eg, healthcare-associated exposure, age, underlying disease, use of antimicrobial agents, etc), *Clostridium difficile* infection (CDI) continues to be a significant problem throughout the world. Despite much effort, CDI rates in the United States have increased in recent years \[[@OFU045C1]\]. In the United States, from 1996 to 2009, CDI rates for hospitalized patients ages ≥65 years increased by 200% \[[@OFU045C2]\]. Beyond causing significant morbidity and mortality, each case of CDI is associated with the addition of several thousand dollars in hospital costs for primary infections and tens of thousands of dollars per case for recurrent infections \[[@OFU045C3]\]. A conservative estimate of the financial burden of CDI in the United States is \$1.1 billion annually \[[@OFU045C4]\]. Costs stem in part from (1) the lack of cost-effective proactive interventions and (2) the lack of means for focusing such interventions based on risk \[[@OFU045C5]\].

In this study, we consider the challenge of building a clinical tool for predicting the risk of inpatients testing positive for pathogenic *C difficile* during a hospital admission. We explore the development of hospital-specific risk stratification based on data that are readily drawn from local electronic health records. This process allows for straightforward integration into the health information system and the automatic calculation of patient risk.

In contrast to previous risk stratification models for CDI, we do not limit ourselves to the set of known risk factors but consider over 10 000 variables automatically extracted from the electronic medical record (EMR). Using machine learning techniques, we develop the model on admissions from a single year and validate the model on a holdout set of admissions from the following year. The holdout set consists of cases that are withheld from the process used to construct the predictive model. We compare our proposed model with one based on a small set of known risk variables.

We show that the addition of information not usually considered can lead to a significant improvement in discrimination performance compared with a model based on a small set of known risk variables. Although building and using such data-driven models may seem more complex than using a simple rule, we argue that the accuracy and hospital specificity makes them more appropriate. Moreover, the growing ubiquity of electronic health systems provides the necessary infrastructure to automate data-driven risk methods, making them easy to construct and use.

METHODS {#s2}
=======

Data {#s2a}
----

The data for this retrospective cohort study came from the electronic databases of a large urban hospital in the U.S. All patients admitted on or after April 12, 2011 and discharged on or before April 12, 2013 were initially considered. Patients \<18 years of age, patients with a length of stay (LOS) \<24 hours, and patients with a positive test for *C difficile* within 24 h of admission were excluded from the analysis. *Clostridium difficile* infection cases were identified using the hospital\'s laboratory database. Admissions in which patients had at least 1 positive result for toxigenic *C difficile* were identified. During the study period, the testing protocol used by the hospital consisted of a DNA amplification assay (illumigene *C difficile*) for the direct detection of *C difficile* toxins A and B in unformed stool.

We define the risk period of a patient as the time from admission to the time of a positive test result or to discharge if the patient never tests positive. In our study population, all patients have a risk period greater than 24 hours. The Institutional Review Board of the Office of Research Integrity of the MedStar Health Research Institute approved the statistical analysis of retrospective medical records.

Feature Extraction {#s2b}
------------------

For each admission in our study population, we extracted 2 sets of variables from the hospital database: Curated Variables: known clinical risk factors for *C difficile* drawn from the literature, and readily available to physicians within 24 hours of admission \[[@OFU045C6]--[@OFU045C20]\].EMR Data: all structured patient data that can be automatically extracted from the EMR within 24 hours of admission.

These 2 sets of variables are described in detail in the next section. The first set of variables, selected by a team of collaborating physicians, represents well known risk factors for *C difficile*. We restricted this set to variables typically available to physicians, eg, we do not consider colonization pressure, which requires information on patient locations to calculate unit-wide and hospital-wide rates of infection with *C difficile* (see [Supplementary Supporting Information](http://ofid.oxfordjournals.org/lookup/suppl/doi:10.1093/ofid/ofu045/-/DC1)). The second set of variables is a much larger set, consisting of structured data that are easily derived in a fully automated manner from the EMR, including colonization pressure. Most of the variables or features we considered were categorical (discrete) and several were continuous. We discretized the continuous data and mapped all data to binary variables.

Learning to Predict Risk {#s2c}
------------------------

We sought to predict in advance which patients would test positive for *C difficile* during the current hospitalization. We chose to make a single prediction for each patient as in reference \[[@OFU045C2]\]. We made the prediction 24 hours after admission to leverage the entries made to the EMR shortly after admission.

After feature extraction, our dataset consisted of patient admissions represented by feature vectors, labeled either positive or negative depending on whether the patient tested positive for *C difficile* during the current admission. Given the labeled data, we sought a function that maps a set of observations about a patient to a scalar value in \[0, 1\] (ie, a probability). This function was learned on training data from the first year using logistic regression, a computationally efficient method for linear classification. Solving for the regression coefficients, ie, feature weights, is an optimization problem (see [Supplementary Supporting Information](http://ofid.oxfordjournals.org/lookup/suppl/doi:10.1093/ofid/ofu045/-/DC1) for more detail). To improve generalizability to unseen future patient cases, we used L2-regularized logistic regression \[[@OFU045C21]\]. The solution to the optimization problem depends on the data used in training. We considered 3 different models: 1 based on the small set of curated risk factors and 2 others that included the longer list of variables extracted automatically from the EMR. Under Results, we compare the performance of the 3 models.

Model Evaluation {#s2d}
----------------

To measure the performance of the models, we applied each model in turn to a set of holdout data from the following year. Validation on a holdout dataset is important when working with a large number of risk variables, because it becomes easier to overfit to the training set with increasing numbers of variables being considered, which can produce deceptively good results. Furthermore, dividing the data temporally (rather than randomly) into a training and validation set mimics how we expect the predictive model learned from historical data to perform in the risk stratification of future patients. Recent hospitalizations are likely to be more similar to the cases that we will see in the future.

Each models\' ability to discriminate low-risk from high-risk patients was measured using the area under the receiver operating characteristic curve (AUROC) \[[@OFU045C21]\]. The 95% confidence interval was calculated using 100 bootstrap samples (sampling with replacement) of the validation set \[[@OFU045C22]\]. To further quantify each model\'s ability to risk stratify the patients in the validation set, we measured the calibration of both models, capturing how closely predicted risk matched actual risk \[[@OFU045C23]\]. We sorted the test patients by their predictions and grouped them by deciles. For each group, we calculated the median predicted probability of risk and the actual probability of risk (for each of the 100 bootstrap samples). We also compared the performance of the models using the Net Reclassification Improvement (NRI) \[[@OFU045C24]\]. We considered grouped NRI instead of continuous NRI because calibration can greatly affect the continuous NRI measurement. To measure NRI for different decision thresholds, we split the validation data into 2 groups, high risk and low risk, sweeping the decision threshold from the 50th percentile to the maximum. Finally, we measured the classification performance of the models, in terms of sensitivity and positive predictive value, using a decision threshold based on the 95th percentile. This threshold was chosen based on the class imbalance (ie, identifies a patient population 5 times greater than the expected number of infected patients). In addition to identifying which patients were predicted to test positive and which patients actually tested positive, we noted when patients tested positive. This method allowed us to determine how far in advance the model is capable of accurately identifying high-risk patients, an important measure of performance for any predictive model. All statistical analyses were performed using MATLAB.

RESULTS {#s3}
=======

After applying exclusion criteria (described in Figure [1](#OFU045F1){ref-type="fig"}), the final population consisted of 69 568 admissions. Table [1](#OFU045TB1){ref-type="table"} summarizes the demographic and admission-related characteristics of the study population. Given the EMRs of all patients in our dataset, we extracted the features referenced in Table [2](#OFU045TB2){ref-type="table"} for each patient admission and a binary label indicating whether a patient tested positive for *C difficile* (and when). This process resulted in 14 curated features and 10 845 additional features derived from the EMR. Table 1.Descriptive Characteristics of Study PopulationVariableStatistic (*n* = 69 568)Female gender (%)56.72Age (%) 18--256.36 25--4520.87 45--6025.23 60--7018.74 70--8015.37 80--10010.37 ≥1002.97Hospital admission type (%) Emergency58.53 Routine elective19.36 Urgent12.43 Term pregnancy9.41Hospital admission source (%) Admitted from home79.34 Transferred from another health institution12.02 Outpatient6.20 Other^\*^2.42Hospital service (%) Medicine45.54 Cardiology12.41 Surgery11.41 Obstetrics10.72 Psychiatry4.21 Other^†^15.71Hemodialysis performed (%)5.02Diabetic (%)31.46Medications (%) Immunosuppressants (solid-organ transplant)1.84 Corticosteroids11.31 Antimicrobials assoc^\*\*^36.67 Antimicrobials rarely assoc18.30 Proton pump inhibitors34.92 CDI (%)1.05 Median LOS in days (IQR)4.01 (2.40--7.12) Previous visit in last 90 days (%)21.85 History of CDI, 1 year (%)1.45[^1][^2][^3][^4] Table 2.Variable Descriptions^\*^Variable NameDescriptionCurated Variables Based on Well Known Risk Factors (All Variables Collected During First 24 H of Admission) age_70(Time of Admission - Birthday) ≥70 years \[[@OFU045C8], [@OFU045C9], [@OFU045C11]\] admission_source:TETransfer from nursing home \[[@OFU045C1]\] day90_hospitRecent hospitalization in the previous 90 days \[[@OFU045C7], [@OFU045C10]\] hist_cdiPrevious CDI within the last year \[[@OFU045C11]\] hemodialysisProcedure code for dialysis \[[@OFU045C10]\] gastro_tubeProcedure code associated with nasogastric or esophagostomy tube \[[@OFU045C16], [@OFU045C19]\] ccsteroidsPOE for corticosteroids \[[@OFU045C10]\] immunosuppressantsPOE for solid-organ transplant immunosuppressants chemo_cdiPOE for chemotherapeutic agents associated with CDI chemo_enteroPOE for chemotherapeutic agents associated with enteropathy antimicrobials_assocPOE for antimicrobials frequently associated with CDI \[[@OFU045C9], [@OFU045C12]--[@OFU045C14], [@OFU045C20]\] antimicrobials_rarelyPOE for antimicrobials rarely associated with CDI \[[@OFU045C6]\] ppiPOE for proton pump inhibitors \[[@OFU045C15], [@OFU045C17]\] abdominal_surgeryProcedure codes for abdominal surgery associated with CDI \[[@OFU045C9], [@OFU045C18]\]Variable CategoryDescriptionCategories of Additional Variables Extracted From the EMR previous visitsStatistics on previous LOS (within 90 days) lengths (total, max, avg) dxcodesHighest level of ICD9 codes coded during most recent visit labresultsAny laboratory test that was observed within 24 h with flag (high, low, critical) vitalsAll vitals with flags (high, low) collected during first 24 h proceduresAll procedure codes collected during first 24 h medicationsAll POE for previous visit and during first 24 h of current visit admission_typeAdmission type admission_sourceAdmission source hospital_serviceHospital service ageDiscretized \[15, 25, 45, 60, 70, 80, 100\] cityCity where the patient resides colonization_pressureUnit and hospital-wide colonization pressure on day of admission[^5][^6] Figure 1.Study population flow diagram.

We learned 3 different models based on different sets of variables. The first model, named EMR, was constructed by first considering all of the features extracted from the EMR (ie, all of the features in Table [2](#OFU045TB2){ref-type="table"}). For computational efficiency, this set of features was reduced to only those features that occurred in at least 1% of the population. The resulting model was trained on 1017 variables. The second model, Curated, considered only the first 14 features listed in Table [2](#OFU045TB2){ref-type="table"}, known risk factors for *C difficile* readily available to clinicians. For completeness, we constructed a third model, EMR~all~, that used all of the features extracted from the EMR (without any filtering). This final model considered all 10 859 features.

We constructed the risk stratification models (eg, identified the set of weights for combining the observations) on admissions from the first year, and we validated the learned prediction rules on all admissions in the second year. Training Set: 34 846 admissions (372 cases of CDI).Validation Set: 34 722 admissions (355 cases of CDI).

We tested the predictive power of each of the models on the validation data and achieved the results displayed in Table [3](#OFU045TB3){ref-type="table"}. This table presents the AUROC. In the third column of Table [3](#OFU045TB3){ref-type="table"}, we consider the performance on all patients in the validation set. Note that this result includes patients who test positive or are discharged between 24 and 48 hours after admission. These cases are arguably the easiest cases to identify (the closer one is to a positive test result or discharge the easier it is to predict). Therefore, to further validate the 3 models, in the last column of Table [3](#OFU045TB3){ref-type="table"} we note the performance of each model on the subset of admissions with a risk period greater than 48 hours: 28 984 admissions, 286 in which the patient tests positive for *C difficile*. The EMR model performs significantly better than the Curated model, on this subset of test patients. Figure [2](#OFU045F2){ref-type="fig"} shows how this trend continues when we consider patients with even longer risk periods. Table 3.Performance of 3 Models Varying in Complexity on the Test Data (*n* = 34 722)^\*^ModelDimensionalityAUC RP \> 24 (95% CI)AUC RP \> 48 (95% CI)EMR10170.8129 (.79--.83)0.7886 (.76--.82)Curated140.7163 (.69--.75)0.6900 (.66--.72)EMR~all~10 8590.8140 (.80--.83)0.7896 (.76--.81)[^7][^8] Figure 2.The area under the receiver operating characteristic curve (AUROC) achieved when both the electronic medical record (EMR) and the Curated models were applied to patients in the validation set. Each comparison considers a different subset of patients based on the length of their risk periods. For example, in the third comparison from the left, all patients have a risk period of at least 72 hours.

In Figure [3](#OFU045F3){ref-type="fig"}A, we plot the ROCs generated by applying the EMR and the Curated models to the validation data. In all 3 plots, we see a clear advantage of the model trained on the EMR data versus the model trained only on the smaller subset of well known risk factors, specifically in the region between 0.05 and 0.25 false-positive rate (shown in Figure [3](#OFU045F3){ref-type="fig"}A(iii)). In Figure [3](#OFU045F3){ref-type="fig"}B, we display the calibration of both models. The Curated classifier, depicted in the last plot, underestimates the probability of testing positive for patients who are at high risk and overestimates the probability for patients who are at low risk, suggesting that it is not well calibrated. Figure 3.(A) Receiver operating characteristic (ROC) curves for the first 2 models listed in [Table 3](#OFU045TB3){ref-type="table"}. The thin dotted lines represent the 95% confidence bounds generated using 100 bootstrap samples from the test data. A(i) shows the ROC curve generated on all admissions in the test data, whereas A(ii) considers only those patients with a risk period of at least 48 hours. A(iii) focuses on only a portion of the ROC curve presented in 3A(ii). (B) B(i) shows the calibration for the EMR model, and B(ii) shows the calibration for the Curated model. The black dashed lines represent perfect calibration, ie, where the predicted probability aligns with the likelihoods seen when the classifier is applied to the test patients (45 degree line).

Figure [4](#OFU045F4){ref-type="fig"}A plots the NRI for different cutoffs (based on percentiles). In general, we see approximately 15% of improvement in the reclassification of positive examples (ie, the EMR classifier does a better job at classifying the patients who eventually test positive for *C difficile*). In addition, Figure [4](#OFU045F4){ref-type="fig"}B gives the confusion matrix for both classifiers when patients were classified as high risk if the predicted probability was greater or equal to the 95th percentile. From the confusion matrices, in Figure [4](#OFU045F4){ref-type="fig"}B, we calculated a 38% increase in sensitivity and a 50% increase in positive predictive value, using the EMR model compared with the Curated model. The EMR model identified 26 additional true positives compared with the Curated model, while identifying fewer false positives. Figure [4](#OFU045F4){ref-type="fig"}C further illustrates the ability of the EMR model to identify patients several days in advance of a positive test result. Figure 4.(A) Net reclassification improvement (NRI) of using the electronic medical record (EMR) model to classify patients as high risk or low risk versus the Curated model. (B) Confusion matrices for both the EMR model and the Curated model, using a decision threshold based on the 95th percentile. (C) Histogram of when patients in the validation set tested positive for pathogenic *C difficile* and the number patients correctly identified as high risk in each group, using the EMR model with same decision threshold as in 4(B).

DISCUSSION {#s4}
==========

Electronic medical record-based methods for patient risk stratification for CDI in advance of disease performed significantly better than methods based on known risk factors, as represented in the Curated model. The EMR model resulted in a 10% improvement in the AUROC over that of the Curated model. For a true positive rate of 0.5, the EMR model would misclassify over 3000 fewer patients a year. The EMR model performed better than the Curated model consistently across patient populations, independent of when patients tested positive for toxigenic *C difficile*. Furthermore, the proposed classifier identified more true positives, while reducing the number of false positives compared with the Curated model. Given the significant class imbalance of the problem (ie, a positive test result occurs in only 1% of the population), simultaneous improvements in sensitivity and specificity is a significant achievement. Despite the large difference in numbers of features considered, the EMR and EMR~all~ models performed nearly identically, confirming that we do not sacrifice classifier performance when filtering variables for computational efficiency.

To the best of our knowledge, this model is the first risk stratification model for CDI based on data automatically extracted from the EMR. Several recent efforts have focused on building more conventional predictive models for CDI based on known risk factors. Results in the literature for the problem of risk stratification for CDI vary greatly, with reported AUROC\'s ranging from 0.63 to 0.88 \[[@OFU045C7], [@OFU045C22]--[@OFU045C24]\]. The variation in classification performance arises from differences in task definitions, study populations, and methods used to generate and evaluate the predictions. For example Garey et al \[[@OFU045C7]\], considered only hospitalized patients receiving broad-spectrum antibiotics, whereas we consider all hospitalized patients. Such differences render simple comparisons among performance measures uninformative. Thus, in a review of prior work, we shall focus on reported methodology rather than on relative performance.

Tanner et al \[[@OFU045C22]\] tested the ability of the Waterlow Score to risk stratify patients at the time of admission for contracting *C difficile*. The Waterlow Score considers 10 variables available at the time of admission, including build and weight for height, skin type and visual risk areas, sex and age, malnutrition, continence, mobility, tissue malnutrition, neurological deficit, and major surgery or trauma. Dubberke et al \[[@OFU045C6]\], identified several additional risk factors for CDI, including colonization pressure, which attempts to capture the exposure to the pathogen from surrounding colonized or infected patients. More recently, Dubberke et al \[[@OFU045C23]\] developed and validated a risk-prediction model based on variables collected at the time of admission and also during the hospitalization to identify patients at high risk of CDI. The final model includes 10 different variables: age, colonization pressure, times admitted to hospital in the previous 60 days, modified acute physiology score, days of treatment with high-risk antibiotics, whether albumin level was low, admission to an intensive care unit, and receipt of laxatives, gastric acid suppressors, or antimotility drugs. Garey et al \[[@OFU045C7]\] used 5 variables (age 50--80, age \>80, hemodialysis, nonsurgical admission, and intensive care unit LOS) to build a risk index for hospitalized patients receiving broad-spectrum antibiotics.

In all of the work discussed above, building risk stratification models for *C difficile* is a 2-step process. In a first step, risk factors for *C difficile* are identified using either logistic regression or based on previously identified risk factors drawn from the literature. This initial step typically results in the use of fewer than a dozen variables. A second step corresponds to constructing a prediction rule (ie, the function used to combine the factors into a risk score). These functions are typically learned based on a training set of example patient cases (patient admissions labeled as either tested positive for *C difficile* or not). This method is appropriate if the number of available learning examples is small, if the variables must be extracted by hand, or if the prediction rule will be implemented by hand. Yet, many hospital databases now contain hundreds of thousands of EMRs on patient hospitalizations. Although these data are available in most hospital database systems, they are often overlooked when building prediction rules given the traditional goal of generating simple clinical rules (eg, back of the envelope addition with a small number of factors). As we have shown, these data can be harnessed via machine learning techniques to learn accurate hospital-specific risk stratification models that take into consideration thousands of variables. The proposed methods yield hospital-specific, risk stratification models that are custom tailored to the distributions, readily available variables, and nuances of individual hospitals.

In this study, we considered the task of predicting which patients would test positive for pathogenic *C difficile* during the current admission, using data collected within the first 24 hours of admission. Framing the problem as such allowed us to measure the utility of the EMR data available shortly after admission. However, this problem formulation resulted in the identification of patients who acquired an infection during the current hospitalization and those who were probably already infected at the time of admission. The Centers for Disease Control and Prevention defines hospital-acquired CDI as a positive test result for *C difficile* at least 3 calendar days after admission \[[@OFU045C25]\]. This policy is aimed at excluding patients admitted with an infection who were tested before day 3. The ability to identify both sets of patients is clinically relevant. In particular, early identification could aid in reducing further transmission of the disease. However, if one is more interested in focusing prevention efforts on hospital-acquired disease, the proposed methods could be used to make a prediction about each patient 72 hours after admission. In addition, the proposed methods could be extended to make multiple predictions throughout a hospitalization. For example, a prediction could be made on a daily basis with the availability of additional EMR data. The ability to identify patients at high risk of acquiring CDI in advance of disease could enable effective, targeted interventions to reduce patient risk.

Currently, avoiding preventable exposure to antibiotics associated with CDI and preventing ingestion of the *C difficile* organism or spore are the core tenants of prevention efforts \[[@OFU045C26]\]. In the absence of effective risk stratification that can focus the allocation of interventions on the patients at highest risk, interventions, such as proactively isolating patients, targeted antimicrobial review, or performing enhanced environment cleaning, are prohibitively expensive \[[@OFU045C27]\]. Only a small fraction of patients become infected with *C difficile* during their hospitalization. Thus, any intervention applied to the entire population is likely to have no positive effect in at least 99% of the admissions. In contrast, our risk stratification model presented in the previous section can identify a population of patients at 6 times the risk of the reference population, enabling the selective targeting of interventions.

Furthermore, this risk stratification method could be incorporated into a clinical study designed to test the efficacy of proactive interventions. For example, a study could focus on protecting high-risk patients from organisms in the environment whether being shed from asymptomatic carriers \[[@OFU045C10]\], carried on the hands of a healthcare worker, or remaining in the room after the previous occupant \[[@OFU045C28]\]. A focused antimicrobial review targeting high-risk patients may be another opportunity for cost-effective CDI prevention. The efficacy of probiotics in preventing infection with *C difficile* is still being investigated \[[@OFU045C9]\]. Currently, such studies are expensive because in the absence of an effective risk stratification model, a large number of patients must be included to power the analysis. The proposed risk stratification model could help identify a better study population (ie, the population of patients at highest risk of acquiring CDI), thereby reducing the total cost while increasing the statistical power of the analysis. Targeting such high-risk groups with an intervention would limit the total number of patients receiving the intervention while increasing the fraction of patients for which the intervention might have a positive effect.

There are several limitations to this work. First, we lack ground truth regarding the outcome of some patients, because not all patients are tested for *C difficile*. It is possible that some patients become colonized during their hospital stay, but they only start showing symptoms of infection after discharge. If these patients are not readmitted to the hospital and tested for *C difficile*, we will not identify them correctly. Future analysis on prospective data should include an extended follow-up period to identify such cases. Second, the potential for statistical correlation among the variables considered in our high-dimensional models limits our ability to accurately identify risk factors. In this work, we consider only linear models. Such an approach yields models that are interpretable as the sum of weights on variables, versus more complex functions of variables associated with nonlinear methods. Even so, more research is needed before we can effectively and succinctly explain why a particular patient is identified as high risk.

Although more complex than traditional tools for calculating patient risk, models that leverage the richness of the EMR can perform significantly better. Moreover, with the advent of the EMR, these more sophisticated models can be integrated directly into the health information system at the hospital.

We have integrated a version of the model based on 1000 variables into the health record system at the hospital. The risk score is computed as a scheduled task that runs once a day on patient data drawn from the hospital\'s health information system, and it provides an updated risk score that is displayed as part of the patient information available throughout the hospital. We are now exploring ways to incorporate this risk score into existing care delivery processes, with the goal of ultimately improving patient care.

Supplementary Data {#s5}
==================

[Supplementary material](http://ofid.oxfordjournals.org/lookup/suppl/doi:10.1093/ofid/ofu045/-/DC1) is available online at *Open Forum Infectious Diseases* (<http://OpenForumInfectiousDiseases.oxfordjournals.org/>).
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[^1]: Abbreviations: assoc, ; CDI, *Clostridium difficile* infection; IQR, interquartile range; LOS, length of stay.

[^2]: ^\*^ Other includes routine admission (unscheduled), transferred form a nursing home, referred and admitted by family physician.

[^3]: ^†^ Other includes burn, gynecology, neurosurgery, open heart surgery, oncology, orthopedics, trauma, vascular.

[^4]: ^\*\*^ assoc refers to known associations between antimicrobials and CDI.

[^5]: Abbreviations: avg, average; CDI, *Clostridium difficile* infection; EMR, electronic medical record; LOS, length of stay; max, maximum; POE, physician order entry.

[^6]: \* We describe each patient admission using 2 sets of variables. We refer to the first set of variables as Curated. The second set of variables consists of all additional data procured from the structured fields of patients\' electronic health records.

[^7]: Abbreviations: AUC, receiver operating characteristic curve; CI, confidence interval; EMR, electronic medical record; RP, risk period.

[^8]: \* We measure performance in terms of AUC of predictions applied to all of the patients present in the hospital 24 h after admission (who have not yet tested positive for *Clostridium difficile*) and also a subset of patients with an RP \>48 h.
